X4 Pharmaceuticals, Inc. (XFOR)
$2.91+4.30%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $274M
- Beta
- 0.35
- P/E (TTM)
- -2.31
- Short % float
- 13.19%
- Days to cover
- 6.0
- SI change
- -7.8%
- 1W
- +2.83%
- 1M
- -14.41%
- vs SPY 1W
- +1.67%
- vs SPY 1M
- -17.40%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on XFOR?
- LOPJLB’s latest quantitative signal on X4 Pharmaceuticals, Inc. (XFOR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is XFOR in?
- X4 Pharmaceuticals, Inc. (XFOR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does X4 Pharmaceuticals, Inc. (XFOR) do?
- X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candidate, XOLREMDI (also known as mavorixafor), is an orally administered, small-molecule antagonist specifically designed to target the chemokine receptor CXCR4. This compound is currently undergoing …